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Abstract
           
            Arrhythmogenic right ventricular dysplasia/cardiomyopathy is a disorder characterized 
by   frequent   ventricular   tachycardia   originating   from   the   right   ventricle   and   fibro-fatty 
replacement of right ventricular myocardium. Though the disorder was originally described 
during surgical ablation of refractory ventricular tachycardia, catheter ablation of tachycardia is 
one of the options for patients not responding to anti arrhythmic agents. Direct current 
fulguration was used in the initial phase followed by radiofrequency catheter ablation. In the 
present day scenario, all patients with risk for sudden cardiac death should receive an 
implantable cardioverter defibrillator. Radiofrequency catheter ablation remarkably reduces the 
frequency of defibrillator therapies. Direct current fulguration can still be considered in cases 
when radiofrequency ablation fails, though it requires higher expertise, general anesthesia and 
carries a higher morbidity. Newer mapping techniques have helped in identification of the site of 
ablation. In general, the success rate of ablation in arrhythmogenic right ventricular dysplasia is 
less than in other forms of right ventricular tachycardias like right ventricular outflow tract 
tachycardia.
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Introduction
               Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD) is a disorder 
characterized   by   fibro-fatty   replacement   of   the   right  ventricular   myocardium,   frequent 
ventricular tachycardia originating from the right ventricle and right heart failure. It was 
originally described by Fontaine et al during surgical ablation of refractory ventricular 
tachycardia1. The first case of ARVD underwent surgical ablation in October 1973 with a simple 
incision made at the site of origin of ventricular tachycardia (VT).   This was successful to 
prevent recurrence of the arrhythmia and contributed to the identification of this disease2. The 
first clinical series of 24 adult cases was published by Marcus et al in19823. The refractory 
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ventricular arrhythmias of ARVD has always been a challenge for the clinician. Catheter 
ablation has been tried in spite of the justifiable fear of perforation of the dysplastic ventricle. 
This short review aims at bringing together the available literature on catheter ablation in 
ARVD.
Therapeutic Options in ARVD                                                                                                       
            Though historically the original description of ARVD was during surgical ablation, 
pharmacological therapy was the initial mode of treatment in most cases. Surgical ablation by 
right ventricular disconnection was resorted to in resistant cases4. Peroperative cryoablation of 8 
cases were reported by Isobe from Japan5. None of the eight patients died during a mean follow 
up of 3.25 year. VT recurred in two patients and a new VT was seen in another patient.  
Endocavitary electrode catheter ablation using direct current shocks of 100 to 320 J was another 
mode   of   therapy   which   was   tried   in   that   period6.   Nowadays,   implantable   cardioverter 
defibrillators (ICD) are being recommended more often to cover the risk of sudden cardiac death 
(SCD) in ARVD. Even then, patients may need pharmacological therapy to reduce the number 
of shocks. Patients having recurrent sustained VT while on optimal medical therapy are 
candidates for catheter ablation.                                                                                                           
 
Catheter Ablation in ARVD                                                                                   
               The   initial   reports   on   catheter   ablation   in   ARVD   were   using   direct   current 
fulguration6,7,8. One of the earliest series of fulguration in ARVD was that of 13 patients  who 
were treated with shocks ranging from 160 to 280 J9. Single or multiple shocks were required in 
up to three sessions. There were two deaths and four of the 11 survivors required antiarrhythmic 
treatment following the fulguration therapy. The mean follow up  was 45 months. With the 
advent of radiofrequency catheter ablation, direct current fulguration went out of vogue. 
Fontaine et al has suggested that fulguration should still be tried if radiofrequency ablation is not 
successful10.   In   their   16   year   experience   of   ablation   in   ARVD,   the   effectiveness   of  
radiofrequency was less than 40% in the first session. At same time, fulguration is effective in 
the same session after ineffective radiofrequency ablation. Complications have disappeared 
since the use of soft and steerable ablation catheters. This work also classifies thoroughly the 
results of VT ablation alone and in combination with antiarrhythmic drugs, definition of 
relapses, etc… But the disadvantage of fulguration is that it requires expertise, general 
anesthesia and more than one session in half the patients.                                             
Radiofrequency Catheter Ablation                                                                                                 
            Radiofrequency catheter ablation for ARVD has been in use since early nineties11. It has 
been suggested that only patients with focal dysplasia are potential candidates for ablation12. 
     Entrainment mapping can be used to characterize reentry circuits in ARVD to guide 
ablation13,14,15. The concept of concealed entrainment was first reported by Fontaine et al in 
198913. This paper stresses the identification of the zone of slow conduction. The concept was 
originally found in a patient with ARVD. It was later extended to other forms of chronic VT 
(post-myocardial infarction), and more recently is used as a marker of the reentry pathway in re-
entrant supraventricular tachycardias. Ellison et al mapped 19 VTs in 5 patients with ARVD. 
Radiofrequency current was applied to the 58 sites where pacing entrained the VT to assess 
acute termination, with only 22% success. Eight of the 19 VTs were rendered noninducible and 
three were modified to a longer cycle length. In two patients ablation at a single site abolished 
two VTs14. Harada et al did entrainment mapping in 8 VTs in 7 patients with ARVD. 
Radiofrequency applications were done at 31 sites identified by mapping and terminated 7 of 
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them15. 
    Endocardial mapping can detect abnormal fragmented electrograms with delayed potentials. 
Pacemapping confirms the ablation site by producing a QRS morphology identical to the clinical 
VT 16. Recently non-contact mapping has been used to guide catheter ablation in ARVD17. The 
endocardial exit point was defined in all three ARVD patients and the diastolic pathway (earliest 
endocardial diastolic activity) was identified in one of them. Catheter ablation was completely 
effective in only one of the three. Reithmann et al used electroanatomic mapping of right 
ventricular endocardial activation as a guide for catheter ablation in patients with ARVD18. Both 
electroanatomic mapping and entrainment procedures were performed in 5 patients. Endocardial 
mapping during tachycardia demonstrated a focal activation pattern with radial spreading of 
activation from the site of earliest activation. The sites of earliest activation were in an 
aneurysmal outflow tract in two patients, at the border of aneurysms near the tricuspid annulus 
in two patients and at the apex of the right ventricle in one. Entrainment mapping showed that 
these were the exit sites of the reentrant circuits. The clinical VTs were noninducible in 4 of the 
5 patients after catheter ablation. During a mean follow up of 7 months, the frequency of ICD 
therapies came down from 49 + 61 episodes per month to 0.3 + 0.5 episodes per month.
            Three dimensional Real-time Positioning Management System (RPM) has also been 
used for guiding ablation in ARVD19. RPM  uses sonomicrometry to determine the spatial 
location of the ablation catheter relative to two reference catheters positioned in the right atrium 
and   right   ventricle.                                                                          
            O'Donnell et al have highlighted the electrophysiological differences between patients 
with   ARVD   and   right   ventricular   outflow   tract   tachycardia   (RVOT   VT)20.   Though 
radiofrequency ablation is the first line treatment for symptomatic RVOT VT, the role is limited 
in ARVD. In their study they compared 33 patients with RVOT VT and 17 patients with ARVD. 
Re-entry was the mechanism of tachycardia in 80% of the ARVD group while 97% of RVOT 
VT had features of triggered automaticity. Partial or complete success was obtained only in 71% 
of patients with ARVD while complete success was obtained in 97% of RVOT VT. The 
recurrence   rate   was   48%   in   ARVD   and   6%   in   RVOT   VT.  
            Ablation of ventricular tachycardias in ARVD still remains a clinical challenge, though 
more and more cases are being reported in the literature21,22,23.                             
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